Ansa Biotechnologies is building a fast and reliable DNA synthesis service to accelerate synthetic biology research. Our core technology is a novel DNA synthesis method based on enzymes that is faster, cleaner, and more accurate than existing methods.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/11/22 | $68,000,000 | Series A |
Altitude Life Science Ventures Blue Water Life Science Fund Carbon Silicon Ventures Codon Capital Fifty Years Fiscus Ventures Horizons Ventures Humboldt Fund Mubadala Capital Northpond Ventures ![]() Peak6 Investments RA Capital Management | undisclosed |
| 10/01/25 | $54,400,000 | Series B |
AIM13 Altitude Life Science Ventures Black Opal Ventures Blue Water Life Science Fund Cerberus Ventures ![]() Fall Line Capital | undisclosed |